Newsroom | 5774 results

Sorted by: Latest

Alternative Medicine
-

Canopy Growth to Report First Quarter Fiscal 2027 Financial Results on August 7, 2026

SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth to report Q1 2027 financial results on August 7 with a conference call at 10:00am ET....
-

New Economist Enterprise Research Highlights Why Integrating Self-Care Into Health Systems Matters

LEVERKUSEN, Germany--(BUSINESS WIRE)--Self-care, when effectively integrated into health systems, can improve health outcomes, expand access to healthcare services and reduce pressure on overstretched health systems, according to new research by Economist Enterprise. The research, supported by Bayer and published in a report titled “Making self-care work: integrating self-care into health systems”, cites existing evidence estimating that self-care practices can deliver approximately US$ 179 bil...
-

NMS Labs Announces Promotion of Gregory Schuh as Chief Financial Officer

HORSHAM, Pa.--(BUSINESS WIRE)--NMS Labs, a national leader in forensic and clinical toxicology services, is pleased to announce the promotion of Gregory Schuh to Chief Financial Officer, effective July 21, 2026. His promotion reflects NMS Labs’ continued investment in operational excellence, financial stewardship, and commercial growth. Greg joined NMS Labs in April 2023 as Controller. In this role, he oversaw the organization’s finance and accounting functions, supporting both day-to-day opera...
-

N-Zyme Biomedical Closes US$4.6 Million Series A Financing to Advance Clinical Development

NEWARK, Del. & WAUWATOSA, Wis.--(BUSINESS WIRE)--N-Zyme Biomedical Closes US$4.6 Million Series A Financing to Advance Clinical Development....
-

Estrigenix Therapeutics Announces Series Seed Financing to Advance ERβ Platform Across Women's Health and Neurodegenerative Diseases

MILWAUKEE--(BUSINESS WIRE)--Estrigenix Therapeutics closed the first tranche of its $2M Series Seed round, led by Talents Fund I, advancing its ERβ platform for women's health....
-

Canopy Growth Announces Participation at Upcoming Canaccord Genuity Growth Conference

SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC) announced it will be participating at the Canaccord Genuity Growth Conference in August 2026. Canopy Growth CEO Luc Mongeau will be presenting on Tuesday, August 11 at 12:00 p.m. The presentation will be publicly accessible via live webcast at https://event.summitcast.com/view/WuFmFdTcA9mVsUGHZJFU62/8jLaQ2EHsfTiWktFQKVomw, and archived for 180 days. Canaccord Genuity's...
-

Definium Therapeutics Announces New Employee Inducement Grants

NEW YORK--(BUSINESS WIRE)--Definium Therapeutics, Inc. (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced the issuance of inducement grants to two newly hired non-executive employees consisting of options to purchase an aggregate of 30,330 common shares of the Company (the "Options") with effective grant dates of July 20, 2026....
-

The Vessyl Opens in Costa Rica as the World's First 4D Sound Wellness Resort

LA FORTUNA, Costa Rica--(BUSINESS WIRE)--As burnout, digital overload and constant distraction become defining challenges of modern life, a new kind of wellness destination has opened in Costa Rica- one designed not to help people escape the world, but to reconnect with it. Set on 118 acres of rainforest beneath the iconic Arenal Volcano, The Vessyl is the world's first 4D Sound Wellness Resort, introducing a new category of immersive hospitality centered on personalized transformation, nervous...
-

Clinigen Appoints Greg Skalicky as Chief Executive Officer

LONDON--(BUSINESS WIRE)--Clinigen, the global pharmaceutical services company, today announced the appointment of Greg Skalicky as Group Chief Executive Officer....
-

Hims & Hers Chief Accounting Officer, Irene Becklund, Announces Departure from the Company

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced its Chief Accounting Officer, Irene Becklund will depart the company after more than seven years, effective October 9, 2026. Becklund will then serve as an advisor to the company for several months to assist with the transition. The company will conduct a search for her permanent successor, with Yemi Okupe, CFO of Hims & Hers, assuming the responsibilities of...